EUVIMEDEUVIMED entdecken
Crossref

A Bioactive Disintegrable Polymer Nanoparticle for Synergistic Vascular Anticalcification

Hossein Adelnia, Shehzahdi Shebbrin Moonshi iD, Yuao Wu, Andrew C Bulmer, Ryan Mckinnon, Jarred William Fastier-Wooller iD, Idriss Blakey iD, Hang Thu Ta iD

ACS Nano · 10.10.2023 · 17 (19) · 18775-18791

DOI: 10.1021/acsnano.3c03041 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, online erschienen am 31.08.2023. Verfasst von Hossein Adelnia und 7 weiteren Autor:innen. Beteiligte Einrichtung: Queensland Micro- and Nanotechnology Centre, Griffith University, Nathan, Queensland 4111, Australia. Hauptthemen laut MEDLINE: Nanoparticles, Vascular Calcification, Polymers. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 72 Literaturangaben. Gefördert von: National Health and Medical Research Council, National Heart Foundation of Australia, University of Queensland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although poly(aspartic acid) (PASP), a strong calcium chelating agent, may be potentially effective in inhibition of vascular calcification, its direct administration may lead to side effects. In this study, we employed polysuccinimide, a precursor of PASP, to prepare targeted polysuccinimide-based nanoparticles (PSI NPs) that not only acted as a prodrug but also functioned as a carrier of additional therapeutics to provide powerful synergistic vascular anticalcification effect. This paper shows that chemically modified PSI-NPs can serve as effective nanocarriers for loading of hydrophobic drugs, in addition to anticalcification and antireactive oxygen species (anti-ROS) activities. Curcumin (Cur), with high loading efficiency, was encapsulated into the NPs. The NPs were stable for 16 h in physiological conditions and then slowly dissolved/hydrolyzed to release the therapeutic PASP and the encapsulated drug. The drug release profile was found to be in good agreement with the NP dissolution profile such that complete release occurred after 48 h at physiological conditions. However, under acidic conditions, the NPs were stable, and Cur cumulative release reached only 30% after 1 week. Though highly effective in the prevention of calcium deposition, PSI NPs could not prevent the osteogenic trans-differentiation of vascular smooth muscle cells (VSMCs). The presence of Cur addressed this problem. It not only further reduced ROS level in macrophages but also prevented osteogenic differentiation of VSMCs in vitro. The NPs were examined in vivo in a rat model of vascular calcification induced by kidney failure through an adenine diet. The inclusion of Cur and PSI NPs combined the therapeutic effects of both. Cur-loaded NPs significantly reduced calcium deposition in the aorta without adversely affecting bone integrity or noticeable side effects/toxicity as examined by organ histological and serum biochemistry analyses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanoparticlesVascular CalcificationPolymersAnimalsCurcuminRatsReactive Oxygen SpeciesMaleRats, Sprague-DawleyPeptidesMuscle, Smooth, VascularDrug CarriersCalciumOsteogenesis

Stichwörter der Autor:innen

anticalcificationantioxidantchronic kidney diseasecurcuminpolysuccinimidevascular calcification

Substanzen

CurcuminReactive Oxygen SpeciesPeptidespolyaspartateDrug CarriersPolymersCalcium

Autor:innen und Institutionen

  • Queensland Micro- and Nanotechnology Centre, Griffith University, Nathan, Queensland 4111, Australia.
  • Australian Institute for Bioengineering and Nanotechnology, University of Queensland, St Lucia, Queensland 4072, Australia.
  • School of Pharmacy and Medical Sciences, Griffith University, Southport, Queensland 4222, Australia.
  • Department Precision Engineering, Graduate School of Engineering, The University of Tokyo, Tokyo 113-8656, Japan.
  • Bioscience Discipline, School of Environment and Science, Griffith University, Nathan, Queensland 4111, Australia.

ORCID-Profile: Shehzahdi Shebbrin Moonshi, Jarred William Fastier-Wooller, Idriss Blakey, Hang Thu Ta

Förderung

  • National Health and Medical Research Council
  • National Heart Foundation of Australia
  • University of Queensland

Zitieren

APA

Adelnia, H., Moonshi, S. S., Wu, Y., Bulmer, A. C., Mckinnon, R., Fastier-Wooller, J. W., Blakey, I., & Ta, H. T. (2023). A Bioactive Disintegrable Polymer Nanoparticle for Synergistic Vascular Anticalcification. ACS Nano, 17(19), 18775-18791. https://doi.org/10.1021/acsnano.3c03041

Vancouver

Adelnia H, Moonshi SS, Wu Y, Bulmer AC, Mckinnon R, Fastier-Wooller JW, et al. A Bioactive Disintegrable Polymer Nanoparticle for Synergistic Vascular Anticalcification. ACS Nano. 2023;17(19):18775-18791. doi:10.1021/acsnano.3c03041

BibTeX
@article{Adelnia2023,
  author = {Adelnia, Hossein and Moonshi, Shehzahdi Shebbrin and Wu, Yuao and Bulmer, Andrew C and Mckinnon, Ryan and Fastier-Wooller, Jarred William and Blakey, Idriss and Ta, Hang Thu},
  title = {A Bioactive Disintegrable Polymer Nanoparticle for Synergistic Vascular Anticalcification},
  journal = {ACS Nano},
  year = {2023},
  volume = {17},
  number = {19},
  pages = {18775--18791},
  doi = {10.1021/acsnano.3c03041}
}
Kostenlos starten →